Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $43.32 in the prior trading day, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) closed at $42.29, down -2.38%. In other words, the price has decreased by -$2.38 from its previous closing price. On the day, 0.59 million shares were traded. CRNX stock price reached its highest trading level at $42.83 during the session, while it also had its lowest trading level at $41.05.
Ratios:
Our goal is to gain a better understanding of CRNX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.07 and its Current Ratio is at 13.07. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $68.
On January 16, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $50.
On December 21, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $35.Jefferies initiated its Hold rating on December 21, 2023, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 15 ’24 when Pizzuti Dana sold 14,375 shares for $44.47 per share. The transaction valued at 639,256 led to the insider holds 27,786 shares of the business.
Struthers Richard Scott sold 40,951 shares of CRNX for $2,013,561 on Apr 04 ’24. The President & CEO now owns 237,835 shares after completing the transaction at $49.17 per share. On Mar 28 ’24, another insider, Okey Stephanie, who serves as the Director of the company, sold 17,500 shares for $46.38 each. As a result, the insider received 811,650 and left with 6,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRNX now has a Market Capitalization of 3375909376 and an Enterprise Value of 2436396288. Its current Enterprise Value per Revenue stands at 607.126 whereas that against EBITDA is -10.999.
Stock Price History:
Over the past 52 weeks, CRNX has reached a high of $49.58, while it has fallen to a 52-week low of $15.76. The 50-Day Moving Average of the stock is -0.63%, while the 200-Day Moving Average is calculated to be 33.44%.
Shares Statistics:
The stock has traded on average 802.23K shares per day over the past 3-months and 595210 shares per day over the last 10 days, according to various share statistics. A total of 77.93M shares are outstanding, with a floating share count of 72.12M. Insiders hold about 7.45% of the company’s shares, while institutions hold 89.35% stake in the company. Shares short for CRNX as of 1713139200 were 5222721 with a Short Ratio of 6.51, compared to 1710460800 on 5009254. Therefore, it implies a Short% of Shares Outstanding of 5222721 and a Short% of Float of 7.35.
